2-[123I]-iodolisuride SPET visualizes dopaminergic loss in de-novo parkinsonian patients: is it a marker of striatal pre-synaptic degeneration?

Müller, T; Eising, E G; Reiners, C; Przuntek, H; Jacob, M; Kuhn, W

Müller, T; Eising, E G; Reiners, C; Przuntek, H; Jacob, M; Kuhn, W.

Affiliation

Müller T; Department of Neurology, St. Josef-Hospital, Ruhr University of Bochum, Germany.

Nucl Med Commun ; 18(12): 1115-21, 1997 Dec.

Article in En | MEDLINE | ID: mdl-9481757

Subject(s)

Brain/diagnostic imaging; Brain/metabolism; Dopamine/metabolism; Lisuride/analogs & derivatives; Parkinson Disease/diagnostic imaging; Parkinson Disease/metabolism; Tomography, Emission-Computed, Single-Photon/methods; Aged; Cerebellum/diagnostic imaging; Cerebellum/metabolism; Corpus Striatum/diagnostic imaging; Corpus Striatum/metabolism; Female; Functional Laterality; Humans; Iodine Radioisotopes/pharmacokinetics; Lisuride/pharmacokinetics; Male; Middle Aged; Nerve Degeneration/pathology; Organ Specificity; Parkinson Disease/physiopathology; Regression Analysis; Synapses; Tissue Distribution

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Parkinson Disease / Brain / Dopamine / Lisuride / Tomography, Emission-Computed, Single-Photon Type of study: Diagnostic_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Nucl Med Commun Year: 1997 Document type: Article Affiliation country: Germany Country of publication: United kingdom

Search on Google

Add to My VHL

XML

PubMed Links